North America
CNBC Economy

The big business of personal protection: How private security became a $50 billion industry

The trendy Hillcrest neighborhood of San Diego, California, was the backdrop for violent acts and hate crimes. Business owners had enough. The Hillcrest Business Association's members in 2024 began paying a third-party service around $400,000 annually for eight hours of unarmed security guard patrol each day. The association plans to add about $150,000 to the budget next year for a second shift. "It's about setting a tone in the neighborhood," said Benjamin Nicholls, the association's executive director. Violent crime in the U.S. has plummeted over recent decades, government data shows. But a series of high-profile incidents involving businesses, politicians and community groups has helped catalyze an explosion of spending on protection services in places such as Hillcrest, providing a boon for providers like Allied Universal. Revenue in the private security sector climbed 17% over the past decade to above $50 billion in 2025, according to Robert H. Perry & Associates. Outsourced services in the U.S. accounted for just over $35 billion, including electronic security systems and manned guarding, the industry broker said. Some think it's a sign of the times: As political and cultural tensions hit a boiling point in the U.S., even pockets of American life once considered mundane feel at risk of becoming scenes of violence. "Who would have thought 10 years ago that you would need to hire private security at a school board meeting or at a town meeting," said Steve Amitay, executive director of the National Association of Security Companies, an industry group. "We live in a very divisive and inflammatory society right now." At the heart of the personal protection boom is Allied Universal, a privately held company with operations in more than 100 countries and annual revenue of about $23 billion. Guards donning Allied Universal's uniforms oversee lines, operate metal detectors and inspect bags at sporting events, music festivals and office buildings. Allied lists more than 80% of Fortune 500 companies among its clients and has supported globally important events such as this summer's World Cup. CEO Steve Jones has publicly shared his ambitions to take the company public. Allied said in a statement to CNBC that "we continue to assess how the company is capitalized" and that its focus is currently on expanding the business and serving customers. Allied bills itself as the seventh-largest private employer in the world, saying it has roughly 800,000 employees. For comparison, that makes its workforce nearly double the size of Target's and more than three times as large as Disney's. In a given week, Allied said it receives approximately 65,000 applications, interviews around 40,000 candidates and hires about 3,500 people for its North America operations.

The big business of personal protection: How private security became a $50 billion industry
Europe
The Guardian

US added 162,000 jobs in August, with unemployment rate holding steady

A job seeker holds a now hiring flyer as they receive information about education careers in Los Angeles, California, on 29 July 2026. Photograph: Patrick T Fallon/AFP/Getty ImagesView image in fullscreenA job seeker holds a now hiring flyer as they receive information about education careers in Los Angeles, California, on 29 July 2026. Photograph: Patrick T Fallon/AFP/Getty ImagesUS unemployment and employment dataUS added 162,000 jobs in August, with unemployment rate holding steadyNumber of new jobs being added has been fluctuating, with private companies adding 38,000 jobs in August The US economy added 162,000 jobs in August, an uptick after a sluggish summer for the labor market. The unemployment rate held steady at 4.1%, still down from its most recent peak of 4.5% last November, according to new data from the Bureau of Labor Statistics (BLS). Despite the relative stability of the unemployment rate, the number of new jobs added to the economy has been fluctuating, going from 214,000 in March down to a 21,000 gain in July and then back up in August. Figures for job growth in June and July were both revised up. After revisions, job growth in June was 31,000 jobs, up from an initial 20,000, and July was revised up by 44,000 jobs, from an initially reported loss of 23,000 to a gain of 21,000. Economists had predicted gains would be at least 50,000 new jobs. Earlier in the week, the payroll firm ADP reported private companies added 38,000 jobs in August, lower than initial expectations and the lowest month for new jobs since January. Meanwhile, outplacement firm Challenger, Gray & Christmas reported that layoffs have been going down and are 41% lower than cuts that were announced by this time last year. Economists have pointed out that the labor market appears to be stalled in a “slow hire, slow fire” state, with neither growth nor contractions in jobs. A separate BLS report from earlier this week showed job openings and layoffs had changed little in July. The number of people quitting their jobs also remained flat, suggesting workers are feeling less confident about their ability to find another job. For many Americans feeling frustrated about the economy, a lackluster job market feels especially painful when paired with rising prices. US inflation has increased significantly since the start of the war with Iran, with the annual inflation rate going from 2.4% in February to 3.4% in July. In May, price increases reached 4.2%, the highest rate since 2023. In recent weeks, persistent inflation has started to have a domino effect in the US economy after a sell-off in the US bond market. Yields for US Treasury bonds have been going up since the start of the Iran war, suggesting that investors are concerned about the long-term health of the economy. Higher yields could push up the price of loans, including mortgages, car loans and the interest rate on student debt, making things even more costly for Americans. Economists are expecting at least one interest rate hike from the US Federal Reserve before the end of the year. Higher interest rates could help lower inflation, but at the risk of destabilizing the labor market. Last week, Kevin Warsh, the Fed chair, gave his debut speech at the Fed’s symposium in Jackson Hole, Wyoming, where he said the Fed was still committed to getting inflation down to its 2% target rate, but held off on making any firm suggestions on the central bank’s next move. “We must be confident that underlying inflation is moving to our objective, clearly and at sufficient speed,” he said. “Otherwise, we have work to do.”

US added 162,000 jobs in August, with unemployment rate holding steady
Europe
BBC Business

AI cancer cures slowed by chip shortage, says UK's biggest tech boss

The boss of the biggest UK-headquartered tech firm has said that artifical intelligence will find a cure for cancer that humans cannot in our lifetimes. Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings, said while modelling how a DNA marker is impacted by cancer was currently "too complex" a problem, computers are "going to solve it" in the future. Haas also told the BBC that AI would lead to widespread humanoid robots in the next five years, but that its current rapid growth was being held up by a shortage of chips needed to build data centres. However, he was sceptical about the idea chips could be manufactured in the UK in the future. Arm designs the brains or CPUs of microchips already used in hundreds of billions of phones, cars, smartwatches and gadgets across the globe. Earlier this summer, the company's peak share price amid the AI boom made it, in cash terms, the most valuable UK-based company in history. Haas, who stepped down from the board of British pharmaceutical giant AstraZeneca in April, told the BBC's Big Boss Interview podcast: "AI is going to... find a cure for cancer that today you and I, other humans [could] not in our lifetimes. I believe in our lifetime, AI will help cure cancer. "Modelling a cell, modelling a human, modelling how a DNA marker is impacted by cancer - it's too complex a problem, not only for humans today, but the computers that run AI. "However, going forward, as we feed more and more of the models into these computers, and the computers get more sophisticated to run the models, they're going to solve it," said Haas, who also holds a key role in Arm's main owner, the Japan-based Softbank, which has a range of investments in tech including in OpenAI. Prof Chris Bakal, from the Institute of Cancer Research, London, and CEO of Sentinal4D, said the real question was no longer whether we use AI, it's what we feed it. He said in labs like his, they are training AI on data generated themselves from patient samples. "It is not scraped from the internet. It does not need a giant data centre to run. The future of medical AI will not belong to whoever builds the biggest computer. It will belong to whoever has the right measurements.

AI cancer cures slowed by chip shortage, says UK's biggest tech boss
North America
CNBC Finance

Automakers urge Congress to permanently ban Chinese connected vehicles in U.S.

DETROIT — Major automakers operating in the U.S. are increasing pressure on Congress to permanently ban the domestic sale, import and manufacturing of Chinese connected vehicles, hardware and software. The Alliance for Automotive Innovation, which represents the vast majority of companies selling vehicles in the U.S., urged congressional leaders in a Thursday letter to make a move before the end of Congress' current session on Jan. 3. "Right now, Chinese automakers are dumping subsidized vehicles with connected software and hardware around the world," John Bozzella, CEO of the group, said in the letter seen by CNBC. "This hasn't happened inside the U.S. yet, but given the scale and urgency of this threat, we urge you to enact a Chinese vehicle, software and hardware ban before adjourning this year and make this policy the law of the land." Midterm elections are also coming up in November, which could affect Congress' momentum. Bozzella's comments come amid bipartisan efforts in the House and Senate to address Chinese vehicles, including legislation advanced by the Senate Commerce Committee that could bar Mercedes-Benz from the U.S. market because Chinese investors hold nearly 20% of the German automaker. The Alliance for Automotive Innovation, which includes Mercedes-Benz, said in the Thursday letter that it wants to work with lawmakers to "achieve a balanced policy so all our member companies continue to succeed and thrive inside the U.S." Automakers have been worried that Chinese rivals like BYD and Geely are flooding global markets, undercutting vehicle prices and threatening domestic production. Those China-based companies have been increasing their vehicle exports to Europe and Central and South America. "Enacting a permanent ban on Chinese vehicles and high-risk hardware and software in the 119th Congress will send a clear and bipartisan message that China's strategy to dominate global automotive manufacturing will be met with a national security policy response from the American government," Bozzella said. Get this delivered to your inbox, and more info about our products and services. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Automakers urge Congress to permanently ban Chinese connected vehicles in U.S.
North America
Yahoo Finance

Dow, S&P 500, Nasdaq Futures Decline As Iran Jitters Spook Markets: DJT, USO, DELL, CRDO Stocks In Focus

U.S. stock futures were sliding in the overnight session late Tuesday amid fresh U.S. strikes on Iranian targets near the critical Strait of Hormuz. Dow futures fell 0.01%, while the S&P 500 and Nasdaq-100 futures declined 0.04% and 0.15%, respectively, at 10:23 PM EDT. On Tuesday, all three benchmark indexes closed lower amid rising political tensions. The Nasdaq Composite led the losses, shedding 271 points to close more than 1% lower. The Dow Jones Industrial Average and S&P 500 fell 0.79% and 0.71%, respectively. The September trading session started with escalating tensions with Iran after the U.S. launched fresh attacks on the Middle Eastern country near Hormuz. U.S. President Donald Trump confirmed the strikes in a post on Truth Social, saying, “The strikes are large and powerful, and in retaliation for the Iranians’ failed attempt at adding sea mines to the Strait, which currently has no mines (They have been completely removed or detonated!), and the Iranians shooting eight missiles, all successfully knocked down, at our Military Base in Jordan. If the failed Nation of Iran retaliates for this very justified attack, they will be hit again at a much harder and higher level, but it will not be the biggest attack of them all, that is waiting in the wings and, when it is over, there will be very little left of the Islamic Republic of Iran!” The U.S. Central Command also posted about the second day of attacks on Iran on X, saying that at 12 p.m. ET on Tuesday, U.S. forces began striking Islamic Revolutionary Guard Corps (IRGC) targets in Iran in retaliation for the “recent attempted attacks by the IRGC against commercial shipping in the Strait of Hormuz and against American service members deployed to the region.” Brett Erickson, Managing Principal, Obsidian Risk Advisors, said in a post on X, “The United States is seeking to strike positions that will allow them to increase traffic through the Strait of Hormuz, thus lengthening the runway the U.S. and world has to impose their own economic warfare on Iran. Every action taken is to serve the purpose of economic warfare. Once each side realizes that the status quo is the best either can accomplish, there will be no need to continue military strikes.” Oil prices climbed higher amid the tensions, with no peace deal options in sight for a war that has dragged on for over six months. Brent crude futures expiring in November were up about 1.38% to trade at $95.96 a barrel at the time of writing. Meanwhile, WTI crude futures expiring in October were trading at $91.26 per barrel, up 1.15%. The rising oil prices pushed the U.S. Treasury yields higher up, with the U.S. 10-year Treasury yield climbing to 4.806%, the highest level since April 2007. The U.S. 30-year Treasury yield was trading at 5.283% at the time of writing. Economist Peter Schiff said in a post on X, “Oil is breaking out, now trading above $90. It won't be long before it's over $100. Not only will this push up the CPI and bond yields, but it will make driving to the polls in November much more costly for voters. The politics get even worse if the Fed hikes rates in September.” On the economic front, the August jobs report is set for release on Friday. Monthly data on the manufacturing and services sectors are also due this week. Trump Media & Technology Group Corp. (DJT): Escalating tensions in the Middle East and their impact on the domestic environment drew attention to Trump’s media company.

Dow, S&P 500, Nasdaq Futures Decline As Iran Jitters Spook Markets: DJT, USO, DELL, CRDO Stocks In Focus
North America
CNBC Finance

ChargePoint CEO says 70% stock surge 'is the beginning of the momentum'

ChargePoint Holdings CEO Rick Wilmer believes a surge in the electric vehicle charging company's stock Thursday is just "the beginning of the momentum," he told CNBC. Shares of ChargePoint soared more than 70% Thursday after the company significantly beat Wall Street's second-quarter expectations for its 2027 fiscal year and guided toward continued improvements in its performance. It's the most notable increase since it underwent a reverse stock split last year to raise its share price and maintain compliance with the New York Stock Exchange's minimum trading price requirement of $1 per share. "The growth is starting to accelerate," Wilmer told CNBC during an interview Thursday morning. "It'll be driven substantially by the new products and technology we're putting into the market." ChargePoint, unlike some EV charging companies, does not actually own and operate its chargers. It provides hardware, software and services to customers, such as businesses, that want to offer chargers to their employees or customers. The company after markets closed Wednesday reported revenue of $116.1 million and a loss per share of 35 cents during the quarter. That compared with analyst expectations of $105.2 million in revenue and a loss of 85 cents, according to average estimates compiled by LSEG. Its performance was assisted by a one-time tariff refund of approximately $4.2 million in the quarter, but the company said its normalized gross margin would have still set a new record without the benefit. "We've now had our fourth consecutive quarter of year-over-year growth, and this quarter we just reported yesterday was obviously another good growth quarter," Wilmer said. "And now [we're] expecting that to accelerate, especially as we move into next year." As part of its growth plan, the company has been introducing faster high-performance chargers, known as "Level 3," in Europe, as well as next-generation products for the U.S., including Level 2 and Level 3 chargers. The company also is using artificial intelligence to improve charging times for its customers, reduce how long it takes to develop software and improve efficiency across its business, Wilmer said. Wilmer's optimism comes despite a slowdown in all-electric vehicle sales during the past year, following the elimination of federal support for the industry in the U.S., including the end of an up to $7,500 consumer benefit for purchasing an EV. "I think, altogether, the down cycle, or the doom and gloom, has been a bit overstated. I think there's a lot more positivity at the ground level," Wilmer said. "I just think in the end, better products can win."

ChargePoint CEO says 70% stock surge 'is the beginning of the momentum'
North America
CNBC Finance

Trump strikes new drug pricing deals with nine midsized drugmakers

President Donald Trump on Monday said he struck new drug pricing deals with nine drugmakers to voluntarily sell their medications for less, building on his push to link the nation's pharmaceutical prices to cheaper ones abroad. The drugmakers signing the new deals are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB, according to the White House. Shares of most of those companies closed relatively flat on Monday, while Teva and BeOne fell around 1%. Under the new deals, the nine companies agreed to provide discounts on outpatient drugs to every state Medicaid program so that prices states pay align with what companies charge in foreign countries. The agreements impact drugs that treat several chronic and rare diseases, such as hemophilia, liver disease, skin conditions and certain forms of cancer. The companies committed to invest at least $19.6 billion collectively in U.S. manufacturing in the near term, according to the White House. Astellas, Sun Pharma, Teva and UCB also agreed to donate active pharmaceutical ingredients for key products to the federal government's strategic reserve of those ingredients, which aims to reduce reliance on foreign supply and ensure the U.S. is prepared in the event of an emergency. For example, UCB will contribute 163 tons of levetiracetam, an anticonvulsant used to control and prevent certain types of seizures. The new agreements bring the Trump administration's total number of drug pricing deals to 26 companies, which the president said represents 90% of the domestic pharmaceutical market. He said the other 10% of the industry is "also coming in" and "have no choice." Over the past year, the Trump administration reached drug pricing deals with 17 other pharmaceutical companies, including Pfizer, Eli Lilly and Novo Nordisk, as part of its "most favored nation" policy. Trump signed an executive order in May 2025 to revive that policy, calling for prices to be increased outside of the U.S. and to "end global freeloading." The deals add to the White House's efforts to spotlight healthcare affordability ahead of the midterm elections. The "most favored nation" deals that have been signed with the Trump administration have already impacted the commercial strategies, bottom lines and manufacturing pipelines of major pharmaceutical companies. To insulate themselves from future tariff threats, drugmakers are spending billions of dollars to bring manufacturing capabilities back to the U.S. Companies are also drastically expanding direct-to-consumer channels for their products, including by offering their medicines on the president's TrumpRx portal. Lower prices in the U.S. are weighing on bottom lines, with manufacturers like Novo Nordisk saying that it will take time for prescription volumes to offset the revenue dip. U.S. prescription drug prices on average are nearly three times higher than they are overseas, according to a 2024 study by Rand Corp. Prices for branded drugs were more than four times higher, the report found. The trade association PhRMA, which represents many major pharma companies, has previously said that most-favored nation pricing isn't the best way to lower drug costs for Americans and instead blamed pharmacy benefit managers for the price disparity.

Trump strikes new drug pricing deals with nine midsized drugmakers
North America
CNBC Finance

Mortgage rates surge to the highest since June 2025 as new Middle East attacks push oil prices up

A jump in oil prices after renewed hostilities in the Iran war is pushing bond yields higher, and mortgage rates are following suit. The average rate on the 30-year fixed loan jumped 6 basis points on Monday to 6.87%, according to Mortgage News Daily. That is the highest level since June 2025. It's now up 12 basis points since Thursday and has risen more than 30 basis points in the last two months. "While rates are technically at their highest level in more than a year, they haven't exactly exploded with surprising, new momentum," said Matthew Graham, chief operating officer at Mortgage News Daily. "Instead, it's been more of a slow grind fueled by the usual suspects: inflation expectations, elevated bond issuance, and economic resilience. All three of those factors are subject to at least some variability in the future." The expectation had been for falling rates this year, but the war with Iran and its resulting rise in oil prices upended that. The day before the war started, at the end of February, the rate on the 30-year fixed was 5.99%. To put that into perspective, for someone buying a $450,000 home, which is right around the national median, putting 20% down on a 30-year fixed mortgage, the monthly principal and interest payment today would be $2,363. That is $207 a month more than it would have been back at the end of February. CNBC's Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox. And that's just the payment. When rates go up, fewer borrowers can qualify for a mortgage, as it shifts the debt-to-income ratios that lenders rely on for safe lending. This comes on top of higher home prices, which seem to now be accelerating again in some parts of the country, due to lean supply. Nationally, prices in June were up 1.5% year over year, up from the 1.2% rise in May, according to the latest S&P Cotality Case-Shiller home price index. "As financing costs are kept high for prospective buyers, current homeowners remain reluctant to give up the low mortgage rates secured in prior years," said Rebecca Kaufman, associate director of commodities at S&P Dow Jones Indices, in a news release. Get this delivered to your inbox, and more info about our products and services. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Mortgage rates surge to the highest since June 2025 as new Middle East attacks push oil prices up
Europe
BBC Business

Next wins key appeal to overturn £30m equal pay ruling

Image source, Getty ImagesByEmma SimpsonBusiness correspondentPublished7 September 2026Next has won an appeal allowing it to keep paying warehouse workers a higher hourly rate than shop floor staff in a long running battle over equal pay. The Employment Appeal Tribunal has overturned a key part of a landmark ruling in 2024 which found the retailer was wrong to pay its warehouse staff higher basic pay than shop floor workers for jobs of equal value. More than 3,500 current and former employees, mainly women, had been set to share potentially more than £30m in back pay as a result of that judgement. After Next's appeal, the law firm Leigh Day, which represents store workers, described the conclusion on basic pay as "disappointing" and said it will appeal the decision. The tribunal accepted that Next was justified in paying higher rates because of recruitment and retention pressures for warehouse workers. Next described the decision as a "landmark victory" succeeding on the "key issue of basic pay". In a statement, it said: "The importance of this decision is that the Appeal Tribunal has confirmed that it was justifiable for Next to rely on market forces to distinguish between different groups of employees, where there was a good rationale to pay one group more than the other. "In this case, Next had to pay a higher market rate to warehouse operatives because of recruitment and retention pressures, which did not apply to the workforce in its stores. Next believes this element of the judgment is not only correct in law, but also a victory for common sense. "The judgment affirms a principle at the heart of any effective employment market - that employers must be able to pay what is necessary to recruit the people they need; and that doing so does not oblige them to raise the pay of other employees where there is no reason to do so." Leigh Day said judges did uphold 2024 findings on night-time premiums, overtime premiums and paid rest breaks. Both the original Employment Tribunal and the Appeal Tribunal found there was no direct sex discrimination in Next's pay rates. Shop floor staff are predominantly women while warehouse workers are predominantly male. Questions are now being asked about if this result could set a precedent across the industry. Tesco, Asda, Morrisons, and Sainbury's are all involved in similar long running claims and will be studying the findings closely.

Next wins key appeal to overturn £30m equal pay ruling